Phase 3 Von Willebrand Disease (vWD) Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Von Willebrand Disease (vWD)
Takeda24 enrolled21 locationsNCT05582993
Recruiting
Phase 3
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Von Willebrand Disease (vWD)
Vega Therapeutics, Inc60 enrolled14 locationsNCT07115004
Recruiting
Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
Von Willebrand Disease (vWD)
Takeda20 enrolled7 locationsNCT07129343